Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin

Frontiers in Pharmacology(2022)10.3389/fphar.2021.805133Source: DataRank Database

Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (12)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Dustyn A. Barnette ORCID,Riley W. Sinnott ORCID,Sarah Phillips ORCID,Noah R. Flynn ORCID,Howard P. Hendrickson ORCID

Live enrichment

PubMed:19910364

National Institutes of Health

Grant: 5R01GM140635-04

Systematic Discovery of Bioactivation-Associated Structural Alerts

National Institutes of Health

Grant: 1R01LM012482-01

Computationally modeling the impact of ontogeny on drug metabolic fate

National Institutes of Health

Grant: 1R01LM012222-01

DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2021.805133/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2021.805133/full

repositoryhttps://digitalcommons.wustl.edu/open_access_pubs/11545

repositoryhttps://doaj.org/article/a8dec47d9bf6442485f60c67345fb8f1

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8793337

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

warfarinhydroxywarfarinPharmacologymodelingreductionTherapeutics. PharmacologyRM1-950anticoagulationmetabolism

Sustainable Development Goals

SDG 3: 3. Good health